[go: up one dir, main page]

ES508145A0 - Procedimiento para la obtencion de soluciones micelares de b-carotina inyectables. - Google Patents

Procedimiento para la obtencion de soluciones micelares de b-carotina inyectables.

Info

Publication number
ES508145A0
ES508145A0 ES508145A ES508145A ES508145A0 ES 508145 A0 ES508145 A0 ES 508145A0 ES 508145 A ES508145 A ES 508145A ES 508145 A ES508145 A ES 508145A ES 508145 A0 ES508145 A0 ES 508145A0
Authority
ES
Spain
Prior art keywords
carotine
procedure
micellar solutions
injectable
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES508145A
Other languages
English (en)
Other versions
ES8300472A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of ES8300472A1 publication Critical patent/ES8300472A1/es
Publication of ES508145A0 publication Critical patent/ES508145A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES508145A 1980-12-19 1981-12-18 Procedimiento para la obtencion de soluciones micelares de b-carotina inyectables. Granted ES508145A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803048000 DE3048000A1 (de) 1980-12-19 1980-12-19 Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8300472A1 ES8300472A1 (es) 1982-11-01
ES508145A0 true ES508145A0 (es) 1982-11-01

Family

ID=6119676

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508145A Granted ES508145A0 (es) 1980-12-19 1981-12-18 Procedimiento para la obtencion de soluciones micelares de b-carotina inyectables.

Country Status (7)

Country Link
US (1) US4435427A (es)
EP (1) EP0055817B1 (es)
CA (1) CA1185185A (es)
CS (1) CS228528B2 (es)
DE (2) DE3048000A1 (es)
ES (1) ES508145A0 (es)
HU (1) HU185159B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
GB9219524D0 (en) * 1992-09-15 1992-10-28 Smithkline Beecham Plc Novel composition
US5260340A (en) * 1992-11-19 1993-11-09 Baranowitz Steven A Prevention and amelioration of acetaminophen toxicity with beta-carotene
DE19609538A1 (de) * 1996-03-11 1997-09-18 Basf Ag Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
DE19609476A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
DE19609477A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile wäßrige Solubilisate von Carotinoiden und Vitamine
EP0807431B1 (en) * 1996-05-14 2004-03-24 DSM IP Assets B.V. Process for the manufacture of carotenoid compositions
DE19653410A1 (de) * 1996-12-20 1998-06-25 Basf Ag Verwendung von Carotinoid-Solubilisaten zum Färben von Lebensmitteln und pharmazeutischen Zubereitungen
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
DE19831865A1 (de) 1998-07-16 2000-01-20 Basf Ag Verwendung von Schwefel-organischen Verbindungen als Mittel zur bathochromen Verschiebung der UV/Vis-Absorptionsbande von Carotinoiden
DE19838636A1 (de) 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
ATE425743T1 (de) * 2001-02-11 2009-04-15 Aquanova Ag Verfahren zur herstellung eines isoflavon- konzentrats
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) * 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
BRPI0313155B8 (pt) 2002-07-29 2021-05-25 Cardax Pharmaceuticals Inc composto químico derivado ou análogo de carotenóide, composição farmacêutica, e, uso do composto
EP1750723A1 (en) * 2004-04-14 2007-02-14 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060183185A1 (en) * 2004-10-01 2006-08-17 Lockwood Samuel F Method for the synthesis of astaxanthin
DE102005032352A1 (de) * 2005-07-08 2007-01-11 Aquanova German Solubilisate Technologies (Agt) Gmbh Solubilisate pfanzlicher Wirkstoffe sowie Verfahren zur Herstellung der Solubilisate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2417299A (en) * 1943-08-06 1947-03-11 Us Vitamin Corp Fat-soluble vitamin solutions
US2518230A (en) * 1947-11-15 1950-08-08 Us Vitamin Corp Aqueous solutions of lipoid-soluble vitamins
US2524247A (en) * 1948-07-10 1950-10-03 Hoffmann La Roche Aqueous solutions of lipoid-soluble vitamins
DE970772C (de) * 1951-06-05 1958-10-30 Wander Ag Dr A Verfahren zur Herstellung waessriger, insbesondere konzentrierter waessriger Loesungen der Vitamine D und/oder D
CH437995A (de) * 1963-11-01 1967-06-15 Hoffmann La Roche Verfahren zur Gewinnung von lipophile Substanzen enthaltenden Präparaten
DE2236899A1 (de) * 1972-07-27 1974-02-07 Philips Patentverwaltung Mit wasser mischbare carotinoidemulsion
US3998753A (en) 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HU185159B (en) 1984-12-28
EP0055817A2 (de) 1982-07-14
US4435427A (en) 1984-03-06
DE3048000A1 (de) 1982-07-15
CS228528B2 (en) 1984-05-14
DE3175119D1 (en) 1986-09-18
EP0055817A3 (en) 1983-03-30
CA1185185A (en) 1985-04-09
ES8300472A1 (es) 1982-11-01
EP0055817B1 (de) 1986-08-13

Similar Documents

Publication Publication Date Title
ES508145A0 (es) Procedimiento para la obtencion de soluciones micelares de b-carotina inyectables.
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES502573A0 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
ES507307A0 (es) Procedimiento para la determinacion de colesterina.
MX7339E (es) Procedimiento mejorado para la obtencion de n- acrilamidas
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES511387A0 (es) Procedimiento para la obtencion de poliesteres.
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES507523A0 (es) Procedimiento para la obtencion de disulfuros de xantogeno.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
ES520119A0 (es) Procedimiento para la obtencion de n-vinilacilaminas ciclicas.
ES501347A0 (es) Procedimiento para la obtencion de cianguanidina trisusti- tuidas, de efecto fungicida
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES502951A0 (es) Procedimiento para la obtencion de 4-aralquil-1,4-dihidro- pirdinas
ES500985A0 (es) Procedimiento para la obtencion de un material adsorvente.
ES522921A0 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES513070A0 (es) Procedimiento para preparar butirotiolactonas.
ES510752A0 (es) Procedimiento para la obtencion de esteres de fenoxipiridilmetilo.
ES511768A0 (es) Procedimiento para la obtencion de i-alquenos.
ES511969A0 (es) Procedimiento para la obtencion de 2-aminoetanoles sustituidos.
ES504844A0 (es) Procedimiento para la obtencion de a-butirolactonas insatu- radas,ab-sustituidas
ES507524A0 (es) Procedimiento para la obtencion de 1-fenil-2-triazolil-1-penten -3-oles sustituidos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009